Saroglitazar: A New Drug to Treat Diabetic Hypertriglyceridemia

Journal Title: Heart Research – Open Journal - Year 2017, Vol 4, Issue 1

Abstract

Dyslipidemia alone has been considered as one of the major modifiable risk factor for cardiovascular diseases (CVD) accounting for 50% of the 1st myocardial infarction (MI) cases worldwide.1 A recent epidemiological survey on prevalence of lipid abnormalities of the Indian population by Indian Council of Medical Research-India Diabetes Study (ICMR-INDIAB), has shown that 79% of Indian subjects above 20 years of age have abnormalities in at least one of the lipid parameters.2 In this survey, the most commonly found lipid abnormality was low-high density lipoprotein cholesterol (low HDL-C) in 72% subjects followed by high triglycerides (TG) in 29.5% subjects and then high low-density lipoprotein cholesterol (LDL-C) in 11.8% subjects.3 Prevalence of dyslipidemia is high in India, which calls for urgent lifestyle and pharmacological intervention strategies to prevent and manage this important cardiovascular risk factor.

Authors and Affiliations

Vineet Bhatia

Keywords

Related Articles

A Comprehensive Cardiovascular Preventive Clinic: Is it a Concept that is Possible to Implement in the Military System?

Cardiovascular disease has a huge impact on our society and the individuals affected. According to the most recent data published by American Heart Association (2014 Update), Coronary heart disease alone caused about 1 i...

Carcinoid Heart Disease: Classical Echocardiographic Features

Carcinoid Heart Disease (CHD) is an important and rare cause of acquired valvular heart disease. Clinical examination supplemented with Echocardiographic evaluation may give the first clue towards an under lying carcinoi...

Experimental Vein Graft Research: A Critical Appraisal of Models

Experimental models of vein grafting need to have specific relevance to the clinical complications encountered in coronary artery bypass grafting: acute thrombosis, neointima associated stenosis, and progression of late-...

Cardiovascular Research: Past, Present and Future

Cardiovascular disease remains a leading cause of death and significant burden on healthcare systems worldwide. While interventional and preventative medicine has considerably changed the face of clinical practice, at th...

Beneficial Effects of Pre-Operative Intra Aortic Balloon Pump Support in High Risk Patients Undergoing Coronary Artery Bypass Graft Surgery

Objective: The purpose of this study was to evaluate the efficacy and the cost-benefit of preoperative Intra-aortic Balloon Pump (IABP) treatment on peri- and post-operative cardiac performance, improved hemodynamic stab...

Download PDF file
  • EP ID EP558259
  • DOI 10.17140/HROJ-4-135
  • Views 142
  • Downloads 0

How To Cite

Vineet Bhatia (2017). Saroglitazar: A New Drug to Treat Diabetic Hypertriglyceridemia. Heart Research – Open Journal, 4(1), 12-17. https://europub.co.uk/articles/-A-558259